B-Cell	0	4	Mast	Mast	NN	B-NP
I-Cell	5	9	cell	cell	NN	I-NP
O	10	17	heparin	heparin	NN	I-NP
O	18	28	stimulates	stimulate	VBZ	B-VP
O	29	38	migration	migration	NN	B-NP
O	39	41	of	of	IN	B-PP
B-Cell	42	51	capillary	capillary	JJ	B-NP
I-Cell	52	63	endothelial	endothelial	JJ	I-NP
I-Cell	64	69	cells	cell	NNS	I-NP
O	70	72	in	in	FW	B-ADVP
O	73	78	vitro	vitro	FW	I-ADVP
O	78	79	.	.	.	O

O	80	89	Migration	Migration	NN	B-NP
O	90	92	of	of	IN	B-PP
B-Cell	93	102	capillary	capillary	JJ	B-NP
I-Cell	103	114	endothelial	endothelial	JJ	I-NP
I-Cell	115	120	cells	cell	NNS	I-NP
O	121	123	is	be	VBZ	B-VP
O	124	126	an	an	DT	B-NP
O	127	136	important	important	JJ	I-NP
O	137	146	component	component	NN	I-NP
O	147	149	of	of	IN	B-PP
O	150	162	angiogenesis	angiogenesis	NN	B-NP
O	163	165	in	in	FW	B-ADVP
O	166	170	vivo	vivo	FW	I-ADVP
O	170	171	.	.	.	O

O	172	181	Increased	Increase	VBN	B-NP
O	182	189	numbers	number	NNS	I-NP
O	190	192	of	of	IN	B-PP
B-Cell	193	197	mast	mast	NN	B-NP
I-Cell	198	203	cells	cell	NNS	I-NP
O	204	208	have	have	VBP	B-VP
O	209	213	been	be	VBN	I-VP
O	214	224	associated	associate	VBN	I-VP
O	225	229	with	with	IN	B-PP
O	230	237	several	several	JJ	B-NP
O	238	243	types	type	NNS	I-NP
O	244	246	of	of	IN	B-PP
O	247	259	angiogenesis	angiogenesis	NN	B-NP
O	259	260	.	.	.	O

O	261	263	We	We	PRP	B-NP
O	264	268	have	have	VBP	B-VP
O	269	273	used	use	VBN	I-VP
O	274	275	a	a	DT	B-NP
O	276	288	quantitative	quantitative	JJ	I-NP
O	289	294	assay	assay	NN	I-NP
O	295	297	in	in	FW	B-ADVP
O	298	303	vitro	vitro	FW	I-ADVP
O	304	306	to	to	TO	B-VP
O	307	318	demonstrate	demonstrate	VB	I-VP
O	319	323	that	that	IN	B-SBAR
B-Cell	324	328	mast	mast	NN	B-NP
I-Cell	329	334	cells	cell	NNS	I-NP
O	335	342	release	release	VBP	B-VP
O	343	344	a	a	DT	B-NP
O	345	351	factor	factor	NN	I-NP
O	352	356	that	that	WDT	B-NP
O	357	370	significantly	significantly	RB	B-VP
O	371	380	increases	increase	VBZ	I-VP
O	381	387	bovine	bovine	JJ	B-NP
B-Cell	388	397	capillary	capillary	JJ	I-NP
I-Cell	398	409	endothelial	endothelial	JJ	I-NP
I-Cell	410	414	cell	cell	NN	I-NP
O	415	424	migration	migration	NN	I-NP
O	424	425	.	.	.	O

O	426	429	The	The	DT	B-NP
O	430	436	factor	factor	NN	I-NP
O	437	439	is	be	VBZ	B-VP
O	440	447	present	present	JJ	B-ADJP
O	448	450	in	in	IN	B-PP
O	451	457	medium	medium	NN	B-NP
O	458	469	conditioned	condition	VBN	B-VP
O	470	472	by	by	IN	B-PP
B-Cell	473	477	mast	mast	NN	B-NP
I-Cell	478	483	cells	cell	NNS	I-NP
O	484	486	as	as	RB	B-CONJP
O	487	491	well	well	RB	I-CONJP
O	492	494	as	as	IN	I-CONJP
O	495	502	lysates	lysate	NNS	B-NP
O	503	505	of	of	IN	B-PP
B-Cell	506	510	mast	mast	NN	B-NP
I-Cell	511	516	cells	cell	NNS	I-NP
O	516	517	.	.	.	O

O	518	521	The	The	DT	B-NP
O	522	533	stimulatory	stimulatory	JJ	I-NP
O	534	540	effect	effect	NN	I-NP
O	541	543	of	of	IN	B-PP
B-Cell	544	548	mast	mast	NN	B-NP
I-Cell	549	554	cells	cell	NNS	I-NP
O	555	557	on	on	IN	B-PP
O	558	567	migration	migration	NN	B-NP
O	568	570	is	be	VBZ	B-VP
O	571	579	specific	specific	JJ	B-ADJP
O	580	583	for	for	IN	B-PP
B-Cell	584	593	capillary	capillary	JJ	B-NP
I-Cell	594	605	endothelial	endothelial	JJ	I-NP
I-Cell	606	611	cells	cell	NNS	I-NP
O	611	612	.	.	.	O

O	613	624	Furthermore	Furthermore	RB	B-ADVP
O	624	625	,	,	,	O
B-Cell	626	630	mast	mast	NN	B-NP
I-Cell	631	636	cells	cell	NNS	I-NP
O	637	641	have	have	VBP	B-VP
O	642	644	no	no	DT	B-NP
O	645	654	mitogenic	mitogenic	JJ	I-NP
O	655	663	activity	activity	NN	I-NP
O	664	667	for	for	IN	B-PP
B-Cell	668	677	capillary	capillary	JJ	B-NP
I-Cell	678	689	endothelial	endothelial	JJ	I-NP
I-Cell	690	695	cells	cell	NNS	I-NP
O	695	696	.	.	.	O

O	697	699	Of	Of	IN	B-PP
O	700	703	all	all	PDT	B-NP
O	704	707	the	the	DT	I-NP
O	708	717	secretory	secretory	JJ	I-NP
O	718	726	products	product	NNS	I-NP
O	727	729	of	of	IN	B-PP
B-Cell	730	734	mast	mast	NN	B-NP
I-Cell	735	740	cells	cell	NNS	I-NP
O	741	747	tested	test	VBN	B-VP
O	747	748	,	,	,	O
O	749	753	only	only	RB	B-NP
O	754	761	heparin	heparin	NN	I-NP
O	762	772	stimulated	stimulate	VBD	B-VP
B-Cell	773	782	capillary	capillary	JJ	B-NP
I-Cell	783	794	endothelial	endothelial	JJ	I-NP
I-Cell	795	799	cell	cell	NN	I-NP
O	800	809	migration	migration	NN	I-NP
O	810	812	in	in	FW	B-ADVP
O	813	818	vitro	vitro	FW	I-ADVP
O	818	819	.	.	.	O

O	820	827	Heparin	Heparin	NN	B-NP
O	828	840	preparations	preparation	NNS	I-NP
O	841	845	from	from	IN	B-PP
O	846	847	a	a	DT	B-NP
O	848	855	variety	variety	NN	I-NP
O	856	858	of	of	IN	B-PP
O	859	866	sources	source	NNS	B-NP
O	867	877	stimulated	stimulate	VBD	B-VP
B-Cell	878	887	capillary	capillary	JJ	B-NP
I-Cell	888	899	endothelial	endothelial	JJ	I-NP
I-Cell	900	904	cell	cell	NN	I-NP
O	905	914	migration	migration	NN	I-NP
O	915	917	to	to	TO	B-PP
O	918	921	the	the	DT	B-NP
O	922	926	same	same	JJ	I-NP
O	927	933	degree	degree	NN	I-NP
O	934	937	but	but	CC	O
O	938	941	did	do	VBD	B-VP
O	942	945	not	not	RB	I-VP
O	946	955	stimulate	stimulate	VB	I-VP
O	956	965	migration	migration	NN	B-NP
O	966	968	of	of	IN	B-PP
O	969	976	several	several	JJ	B-NP
O	977	982	other	other	JJ	I-NP
B-Cell	983	987	cell	cell	NN	I-NP
O	988	993	types	type	NNS	I-NP
O	993	994	.	.	.	O

O	995	998	The	The	DT	B-NP
O	999	1008	migration	migration	NN	I-NP
O	1009	1017	activity	activity	NN	I-NP
O	1018	1020	of	of	IN	B-PP
O	1021	1028	heparin	heparin	NN	B-NP
O	1029	1032	and	and	CC	I-NP
B-Cell	1033	1037	mast	mast	NN	I-NP
I-Cell	1038	1042	cell	cell	NN	I-NP
O	1043	1054	conditioned	conditioned	JJ	I-NP
O	1055	1061	medium	medium	NN	I-NP
O	1062	1065	was	be	VBD	B-VP
O	1066	1073	blocked	block	VBN	I-VP
O	1074	1076	by	by	IN	B-PP
O	1077	1085	specific	specific	JJ	B-NP
O	1086	1097	antagonists	antagonist	NNS	I-NP
O	1098	1100	of	of	IN	B-PP
O	1101	1108	heparin	heparin	NN	B-NP
O	1109	1110	(	(	(	O
O	1110	1119	protamine	protamine	NN	B-NP
O	1120	1123	and	and	CC	O
O	1124	1134	heparinase	heparinase	NN	B-NP
O	1134	1135	)	)	)	O
O	1135	1136	,	,	,	O
O	1137	1140	but	but	CC	B-PP
O	1141	1144	not	not	RB	I-PP
O	1145	1147	by	by	IN	B-PP
O	1148	1162	chondroitinase	chondroitinase	NN	B-NP
O	1163	1166	ABC	ABC	NNP	I-NP
O	1166	1167	.	.	.	O

O	1168	1171	The	The	DT	B-NP
O	1172	1181	migration	migration	NN	I-NP
O	1182	1190	activity	activity	NN	I-NP
O	1191	1193	of	of	IN	B-PP
B-Cell	1194	1198	mast	mast	NN	B-NP
I-Cell	1199	1203	cell	cell	NN	I-NP
O	1204	1215	conditioned	conditioned	JJ	I-NP
O	1216	1222	medium	medium	NN	I-NP
O	1223	1226	was	be	VBD	B-VP
O	1227	1236	resistant	resistant	JJ	B-ADJP
O	1237	1239	to	to	TO	B-PP
O	1240	1244	heat	heat	NN	B-NP
O	1245	1246	(	(	(	O
O	1246	1249	100	100	CD	B-NP
O	1250	1257	degrees	degree	NNS	I-NP
O	1258	1259	C	C	NN	I-NP
O	1259	1260	)	)	)	O
O	1261	1264	and	and	CC	O
O	1265	1275	incubation	incubation	NN	B-NP
O	1276	1280	with	with	IN	B-PP
O	1281	1292	proteolytic	proteolytic	JJ	B-NP
O	1293	1300	enzymes	enzyme	NNS	I-NP
O	1300	1301	.	.	.	O

O	1302	1307	These	These	DT	B-NP
O	1308	1315	results	result	NNS	I-NP
O	1316	1323	suggest	suggest	VBP	B-VP
O	1324	1328	that	that	IN	B-SBAR
O	1329	1332	the	the	DT	B-NP
O	1333	1337	role	role	NN	I-NP
O	1338	1340	of	of	IN	B-PP
B-Cell	1341	1345	mast	mast	NN	B-NP
I-Cell	1346	1351	cells	cell	NNS	I-NP
O	1352	1354	in	in	IN	B-PP
O	1355	1367	angiogenesis	angiogenesis	NN	B-NP
O	1368	1371	may	may	MD	B-VP
O	1372	1374	be	be	VB	I-VP
O	1375	1377	to	to	TO	B-VP
O	1378	1385	enhance	enhance	VB	I-VP
O	1386	1395	migration	migration	NN	B-NP
O	1396	1398	of	of	IN	B-PP
O	1399	1402	the	the	DT	B-NP
B-Cell	1403	1414	endothelial	endothelial	JJ	I-NP
I-Cell	1415	1420	cells	cell	NNS	I-NP
O	1421	1423	of	of	IN	B-PP
O	1424	1431	growing	grow	VBG	B-NP
B-Tissue	1432	1443	capillaries	capillary	NNS	I-NP
O	1443	1444	.	.	.	O

